Safety and effectiveness of drug-coated balloon angioplasty in de novo coronary lesions: 6-month outcomes from a multicenter registry
Drug-coated balloon (DCB) angioplasty has emerged as a promising alternative to drug eluting stent (DES) implantation, particularly in small-vessel coronary disease (defined as target vessels with a reference diameter ≤2.75 mm). Nevertheless, multicenter real-world data focusing exclusively on de novo lesions remain...